NEW YORK,  March 12 – DoubleTwist CEO John Couch said Monday that the company’s withdrawal of its IPO last week was nothing but “a tactical financial move,” noting that the company has enough cash to last through the year.

While leaving open the possibility of raising money through a private placement or a merger, Couch said he would focus on boosting the company’s revenues from subscriptions to its annotated databases of genomic data and associated bioinformatics tools. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.